|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:ATCCode
|
gptkb:N02BA01
B01AC06
|
|
gptkbp:bioavailability
|
80-100%
|
|
gptkbp:CASNumber
|
50-78-2
|
|
gptkbp:contraindication
|
Peptic ulcer
Aspirin allergy
Hemophilia
|
|
gptkbp:developer
|
gptkb:Bayer
|
|
gptkbp:drugClass
|
gptkb:Antiplatelet_agent
nonsteroidal anti-inflammatory drug
|
|
gptkbp:eliminationHalfLife
|
2-3 hours
|
|
gptkbp:excretion
|
Renal
|
|
gptkbp:hasFirstMarketed
|
1899
|
|
gptkbp:hasInChIKey
|
BSYNRYMUTXBXSQ-UHFFFAOYSA-N
|
|
gptkbp:hasLogP
|
1.19
|
|
gptkbp:hasMolecularFormula
|
C9H8O4
|
|
gptkbp:haspKa
|
3.5
|
|
gptkbp:hasSMILES
|
CC(=O)Oc1ccccc1C(=O)O
|
|
gptkbp:hasUNII
|
R16CO5Y76E
|
|
gptkbp:hasWikipediaPage
|
https://en.wikipedia.org/wiki/Aspirin
|
|
gptkbp:hasYearOfDiscovery
|
1897
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
CHEMBL429
|
|
gptkbp:indication
|
gptkb:Pain
Fever
Inflammation
Prevention of cardiovascular events
|
|
gptkbp:legalStatus
|
gptkb:OTC
|
|
gptkbp:mechanismOfAction
|
Cyclooxygenase inhibitor
|
|
gptkbp:meltingPoint
|
135°C
|
|
gptkbp:metabolism
|
Hepatic
|
|
gptkbp:molecularWeight
|
180.16
|
|
gptkbp:name
|
gptkb:Aspirin
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:proteinBinding
|
80-90%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL429
2244
DB00945
|
|
gptkbp:routeOfAdministration
|
gptkb:Oral
Rectal
|
|
gptkbp:sideEffect
|
Allergic reactions
Bleeding
Gastrointestinal irritation
|
|
gptkbp:status
|
Approved
|
|
gptkbp:synonym
|
gptkb:ASA
gptkb:Acetylsalicylic_acid
|
|
gptkbp:target
|
gptkb:PTGS2
gptkb:PTGS1
|
|
gptkbp:bfsParent
|
gptkb:vildagliptin
|
|
gptkbp:bfsLayer
|
6
|